Published in Science on August 17, 1984
Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A (2000) 4.53
Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A (1994) 1.59
Leukotrienes in inflammation. Agents Actions (1986) 1.20
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci U S A (2012) 1.13
Analgesic and Anti-Inflammatory Properties of Extracts from the Bulbils of Dioscorea bulbifera L. var sativa (Dioscoreaceae) in Mice and Rats. Evid Based Complement Alternat Med (2010) 1.10
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses. Br J Pharmacol (1988) 1.04
Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol (2008) 0.98
Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. Proc Natl Acad Sci U S A (1986) 0.95
Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol (2007) 0.93
The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats. Br J Pharmacol (2003) 0.90
Pathogenesis of postoperative oral surgical pain. Anesth Prog (2003) 0.89
Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.89
Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells. Proc Natl Acad Sci U S A (1994) 0.88
TRPV1 splice variants: structure and function. Front Biosci (Landmark Ed) (2010) 0.86
Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. PLoS One (2013) 0.86
Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One (2010) 0.86
Cooperative role of tumour necrosis factor-α, interleukin-1β and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice. Br J Pharmacol (2011) 0.85
Antinociceptive and anti-inflammatory effects of a mucin-binding agglutinin isolated from the red marine alga Hypnea cervicornis. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.85
Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits. Br J Pharmacol (1994) 0.83
Phytochemical, analgesic and anti-inflammatory effects of the ethylacetate extract of the leaves of Pseudocedrella kotschyii. Afr J Tradit Complement Altern Med (2007) 0.83
The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors. Br J Pharmacol (2009) 0.79
Potentiation of pentazocine analgesia by low-dose naloxone. J Clin Invest (1988) 0.79
Hyperalgesic pain: a review. Anesth Prog (1991) 0.79
Anti-inflammatory activity of Choisya ternata Kunth essential oil, ternanthranin, and its two synthetic analogs (methyl and propyl N-methylanthranilates). PLoS One (2015) 0.78
Analgesic and anti-inflammatory activities of leaf extract of Mallotus repandus (Willd.) Muell. Arg. Biomed Res Int (2014) 0.76
Analgesic and anti-inflammatory activities of bupropion in animal models. Res Pharm Sci (2015) 0.76
Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction. Basic Res Cardiol (1990) 0.75
Analgesic and Antipyretic Activities of Methanol Extract and Its Fraction from the Root of Schoenoplectus grossus. Evid Based Complement Alternat Med (2016) 0.75
The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons. J Biol Chem (2017) 0.75
Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat. Neuroscience (2016) 0.75
Proceedings of the British Pharmacological Society. 18th-20th December 1985. Abstracts. Br J Pharmacol (1986) 0.75
Navigating the sea of eicosanoids. West J Med (1985) 0.75
CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells. PLoS One (2014) 0.75
Lithothamnion muelleri treatment ameliorates inflammatory and hypernociceptive responses in antigen-induced arthritis in mice. PLoS One (2015) 0.75
Synthesis and pharmacological evaluation of carvacrol propionate. Inflammation (2014) 0.75
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol (1989) 4.37
The mechanism of placebo analgesia. Lancet (1978) 4.10
A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J Exp Med (1972) 3.75
Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest (1977) 3.10
The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 2.93
Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide. Biochemistry (1970) 2.88
Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A (1996) 2.84
A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron (1999) 2.82
Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol (1975) 2.73
Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A (1975) 2.56
Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem (1998) 2.49
Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Pain (1992) 2.49
Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest (1980) 2.37
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis (2005) 2.34
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst (2001) 2.27
Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med (1996) 2.27
Tumor-associated eosinophilotactic factor. N Engl J Med (1974) 2.27
Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils. J Exp Med (1979) 2.20
Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci (2000) 2.20
O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol (1985) (1986) 2.16
The rate of progression of scotomas in glaucoma. Am J Ophthalmol (1986) 2.13
Mechanical transduction by rat dorsal root ganglion neurons in vitro. Neurosci Lett (1999) 2.11
Characteristics of the cofactor requirements for the superoxide-generating NADPH oxidase of human polymorphonuclear leukocytes. Biochemistry (1981) 2.11
Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med (1981) 2.09
Molecular and cellular mechanisms of leukocyte chemotaxis. Science (1981) 2.07
Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J Exp Med (1984) 2.03
Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). J Immunol (1978) 2.02
Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest (1984) 1.94
Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase. Biochemistry (1986) 1.94
Functional isolation and characterization of human hematopoietic stem cells. Science (1995) 1.92
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol (1999) 1.92
Characterization of six voltage-gated K+ currents in adult rat sensory neurons. J Neurophysiol (1996) 1.91
Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 1.89
Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci (1998) 1.88
A new role for cryptochrome in a Drosophila circadian oscillator. Nature (2001) 1.85
Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol (1982) 1.84
Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci (1986) 1.84
Biostatistical evidence for two distinct chronic open angle glaucoma populations. Br J Ophthalmol (1990) 1.83
Mediators of immediate hypersensitivity derived from arachidonic acid. N Engl J Med (1980) 1.83
Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest (1974) 1.81
Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J Immunol (1982) 1.80
Intraneuronal substance P contributes to the severity of experimental arthritis. Science (1984) 1.77
Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci (1990) 1.77
Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med (1971) 1.70
Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity. J Cell Biol (1990) 1.67
A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett (1998) 1.67
The narcotic antagonist naloxone enhances clinical pain. Nature (1978) 1.66
Specific stimulation of human T lymphocytes by substance P. J Immunol (1983) 1.65
Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience (2008) 1.65
Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. Am J Med (1970) 1.65
Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature (1979) 1.63
Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci (1999) 1.63
Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience (1989) 1.62
Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience (1987) 1.62
Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis. J Exp Med (1976) 1.61
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Molecular analysis of mammalian timeless. Neuron (1998) 1.60
Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation. Neurology (1999) 1.59
Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A (1985) 1.59
Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett (1997) 1.57
Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med (1985) 1.54
Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience (1991) 1.54
Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro. Neuroscience (1996) 1.53
Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors. Immunology (1975) 1.52
Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun (1983) 1.51
Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. Biochem Biophys Res Commun (1980) 1.50
Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci (2001) 1.49
A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. J Immunol (1973) 1.45
Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem Biophys Res Commun (1997) 1.45
Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci (1999) 1.44
The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol (2001) 1.44
Transient attenuation of protein kinase Cepsilon can terminate a chronic hyperalgesic state in the rat. Neuroscience (2003) 1.42
Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol (1985) 1.42
Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med (1975) 1.42
Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors. Immunology (1979) 1.42
Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol (2000) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol (1991) 1.41
Structural and catalytic properties of the solubilized superoxide-generating activity of human polymorphonuclear leukocytes. Solubilization, stabilization in solution, and partial characterization. Biochemistry (1979) 1.41
Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther (1998) 1.41
Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol (1974) 1.40
Development of donor-specific isohemagglutinins following pediatric ABO-incompatible heart transplantation. Am J Transplant (2012) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol (1989) 1.38
Functional characterization of synthetic leukotriene B and its stereochemical isomers. J Exp Med (1981) 1.37
Neuroimmunology. Adv Immunol (1986) 1.37
The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 1.36
"Streaking leukocyte factor," arthritis, and pyoderma gangrenosum. Pediatrics (1975) 1.35
Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. Pain (2005) 1.34
Cloning and expression of the human vasoactive intestinal peptide receptor. Proc Natl Acad Sci U S A (1991) 1.34
Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol (1982) 1.33
The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain (1999) 1.33
Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood (1982) 1.32
Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann N Y Acad Sci (1975) 1.32
Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives. J Clin Invest (1979) 1.32